Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Partner · Grade C

Willow review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.

$299/mo
Consult Medication Shipping
See plans at Willow
  • Confirm HSA / FSA coverage
  • Public signup path reviewed
  • Confirm your total cost

We may earn a referral fee

Willow at a glance

Semaglutide
From $299/mo
Tirzepatide
From $399/mo
Coverage
36 states
Brand-name
Compounded only

How we scored Willow

Every factor comes from Willow's own published pricing, disclosures and oversight, and the six combine into the 66/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance58/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit72/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs76/100 · Fair

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost62/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support72/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness52/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

$299/mo semaglutide and $399/mo tirzepatide, published openly on the product pages instead of behind a quiz — rarer in this market than it should be. Two things to settle before you start: the fee moves with your dose, by Willow's own terms, and it operates in 36 states rather than all fifty.

What to expect when you sign up

We walked Willow's public signup — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.

  1. 1Every price is public on its own product page — no quiz, no email gate, no account needed
  2. 2Step 1 of the funnel asks your state from a dropdown listing all 50; there is no warning beforehand that Willow serves only 36, and unsupported states are bounced to a waitlist page only after you submit
  3. 3Supported states move to name and personal details, then a health-history form — 'you'll share your health, lifestyle, and medical history in a short online form'
  4. 4A licensed physician reviews the form asynchronously and, if eligible, prescribes; Willow advertises same-day approval, which only an async review makes possible

What we noticed

  • Pricing is not flat: the Terms state the fee 'may be increased or decreased if your prescription changes, such as by a dosage increase', and the FAQ hedges that 'medication costs vary by dosage and prescription' — the flat-$299 claim circulating on review sites is not supported by Willow's own documents
  • Three compounding pharmacies are named in the Terms — Red Rock Home Pharmacy (UT), Epiq Pharmacy (TX) and The Pharmacy Hub (FL) — with addresses and phone numbers, which is well above average disclosure
  • A named Chief Medical Officer (Dr. Michael Green, MD) and roughly forty-five individually named physicians with bio pages — most competitors name nobody
  • Three different cancellation windows appear across three Willow pages: 'at least 2 business days' in the FAQ, 'two (2) full calendar days' in the Terms, and refunds only 'within 24 hours of order placement' in the Informed Consent
  • Labs and bloodwork are never mentioned anywhere on the site — not included, not offered, not required — and there is no coaching or dietitian benefit
  • The Terms are dated 11.24.2021 and still describe the business as 'women's health services', and the cancellation contact URL they point to is dead

Pricing

MedicationPricePlan
Compounded semaglutide$299InjectionPosted on Willow's semaglutide page with no quiz. Treat it as a starting price: Willow's FAQ says medication costs vary by dosage.
Compounded tirzepatide$399InjectionPosted on Willow's tirzepatide page. Also a starting price that can rise with the dose.
Oral semaglutide$299Sublingual tablet, needle-freeA daily tablet dissolved under the tongue, at the same starting price as the injection.
Oral tirzepatide$399Sublingual tablet, needle-freeA daily tablet dissolved under the tongue, at the same starting price as the tirzepatide injection; Willow's FAQ now lists both tablets.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Willow's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

Prices move. Check today's number for your dose.See plans at Willow

What we like

  • Both molecules offered as sublingual tablets as well as injections — a genuinely uncommon menu
  • Names a Chief Medical Officer and roughly forty-five individual physicians with bio pages, plus three compounding pharmacies with addresses — far more disclosure than most providers we review
  • Every price is posted publicly per product, with no quiz, email gate or account required
  • The plan price bundles medication, the medical evaluation, unlimited physician messaging and free shipping, with no additional fees stated

The caveats

  • Dropped claims that its compounded semaglutide was 'comparable to FDA-approved' products and produced weight loss 'without diet or exercise' only after the National Advertising Division referred it to the FTC and state attorneys general
  • The fee scales with your dose — $299 and $399 are starting prices, and no per-dose table is published anywhere
  • Three different cancellation windows appear across three of its own pages: two business days, two calendar days, and 24 hours from order
  • Available in 36 states, but the signup form offers all fifty and only rejects you after you submit
  • No lab work is mentioned anywhere on the site, and there is no coaching or dietitian benefit
  • Its Terms are dated 2021, still describe the business as 'women's health services', and point cancellations at a dead URL
  • Sublingual GLP-1 tablets are far less studied than the injectables the pivotal trials used
  • Breastfeeding appears only as an exclusion criterion, and there is no postpartum content at all

Weighed the likes and the caveats? See the plans for yourself.See plans at Willow

The most open provider here about who, and the loosest about what

Willow publishes more about itself than almost anyone on our list. A named Chief Medical Officer. Roughly forty-five individual physicians with bio pages. Three compounding pharmacies, with addresses. Every price posted publicly, per product, with no quiz, no email gate and no account required. If you have read a dozen of these pages and grown tired of "a network of licensed providers" and "contact us for pricing", this is the opposite of that, and it is genuinely to Willow's credit.

And it dropped claims that its compounded semaglutide was "comparable to FDA-approved" products, and produced weight loss "without diet or exercise", only after the National Advertising Division referred it to the FTC and state attorneys general. Both of those things are true about the same company. Being unusually forthcoming about your clinicians and unusually loose about your claims are not opposites — and a reader deciding tonight needs both, not an average of them.

The price moves with your dose, and the starting figure is a floor

Semaglutide starts at $299 a month and tirzepatide at $399, injection or sublingual tablet. Those are starting prices: by Willow's own terms the fee scales with your dose, and no per-dose table is published anywhere. So the figure you see is the figure at the bottom of the ladder, and the one you will actually pay at a maintenance dose is not published at all.

That is worth pricing honestly before you start, because titration is not optional — it is how these medications are meant to be taken. Ask what the fee is at the dose you expect to reach, not at the one you begin on.

  • Semaglutide: from $299/mo — injection or needle-free sublingual tablet
  • Tirzepatide: from $399/mo — injection or sublingual tablet
  • Included: medication, the medical evaluation and unlimited follow-up in the plan price
  • Disclosed: a named CMO, ~45 named physicians, three named pharmacies with addresses
  • Coverage: 36 states, not all fifty

Three cancellation windows, on three of its own pages

Willow states three different cancellation windows across three different pages of its own site. That is not a trap so much as a mess, but it has the same effect on you: if you need to stop, the terms you are held to are whichever ones the company decides apply. Get the cancellation window confirmed in writing, from a person, before the first charge — and keep the reply.

Who this suits

Someone who values knowing exactly which physician and which pharmacy stands behind her prescription, wants a needle-free tablet option, and lives in one of the 36 states served. Go in knowing the advertised price is a floor that rises with your dose, and settle the cancellation terms first. The disclosure here is real and unusually good; the advertising history is the reason to read the fine print anyway.

The bottom line for mothers

Best for: Mothers in one of its 36 states who want a sublingual GLP-1 rather than a weekly injection, value knowing exactly which doctor and which pharmacy are behind the prescription, and will get the price at their target dose in writing.

Alternatives to Willow

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.

    Visit Sprout Health
  • $165/mo semaglutide and $214/mo tirzepatide month to month, dropping to $97 and $177 on a 12-month plan — with a genuinely itemized exclusion list that explicitly screens out pregnancy, planned pregnancy, and breastfeeding rather than staying silent on it.

    Visit HealthRX

Providers like Willow

Keep comparing Willow

Willow, answered

Does Willow really offer GLP-1 tablets instead of injections?
Yes — Willow sells sublingual semaglutide and tirzepatide tablets on their own product pages, alongside the usual injections. For a mother who has been putting this off because of the needle, that is a real reason to look. Set expectations honestly, though: these are compounded sublingual formulations, and that route is far less studied than the weekly injection the pivotal trials used, so the published outcome numbers do not automatically carry over.
What does Willow actually cost per month?
Semaglutide is $299 a month and tirzepatide $399, injection or sublingual tablet, all posted openly without a quiz — which is more transparency than most of this market offers. The catch is that these are starting prices. Willow's Terms say the fee 'may be increased or decreased if your prescription changes, such as by a dosage increase', and its FAQ adds that costs 'vary by dosage and prescription'. So the flat-$299-at-every-dose claim you may have read elsewhere is not what Willow's own documents say. No per-dose table is published, and there is no intro or first-month rate on its site. Get your target dose quoted in writing.
Is Willow available in my state?
Willow lists 36 states in its FAQ. Worth knowing before you start: the signup form opens with a dropdown of all fifty, with no warning about limits — enter an unsupported state and you are bounced to a waitlist page after submitting. One note if you are comparing sources: some affiliate directories carry an 18-state exclusion list for Willow that is wrong on four. Maine, Massachusetts, Tennessee and Wyoming are all served — we confirmed that both in Willow's published list and by walking the live state gate. Washington DC, which those directories imply is available, is not served.
Has Willow been in trouble over its advertising?
Yes, and it is recent enough that you should know. After a challenge by Novo Nordisk, the National Advertising Division recommended in December 2025 that Willow drop or modify safety and efficacy claims for its compounded semaglutide. Willow refused, and NAD referred the matter to the FTC and state attorneys general. In July 2026 Willow returned to NAD following discussion with the FTC and voluntarily dropped the claims — including that its products were comparable to FDA-approved semaglutide and produced weight loss without diet or exercise. In fairness, this concerns marketing language rather than any finding about the medication, and a separate Eli Lilly suit against Willow was dismissed with prejudice in February 2026. But a company that had to be walked to the FTC before withdrawing 'no diet or exercise' claims is telling you something about how it sells.
Does Willow handle postpartum or breastfeeding timing?
No. Willow states it is available to adults who are 'not pregnant or breastfeeding' — that is an exclusion, not guidance — and it publishes nothing on postpartum care at all. There is a single PCOS article and no PCOS program behind it. The practical points still apply: semaglutide's labeling asks for a two-month stop before a planned pregnancy, tirzepatide carries no such washout, and the injectable labels do not prohibit breastfeeding — they ask you and your clinician to weigh breastfeeding benefits against clinical need; milk-transfer data do not establish infant safety. If timing around nursing is your real question, a provider whose clinicians will discuss it fits better.

Have a question we didn't answer? Willow's team can.See plans at Willow

Pricing, states and verification reflect Willow's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers